Indulekha P. Sudhakaran

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.

Distinct Molecular Mechanisms Underlie Modulation of Seeded α-Synuclein Aggregation and Toxicity by Salvianolic Acid B and Dihydromyricetin.

Journal: International journal of molecular sciences

Published: March 08, 2026

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Journal: Journal of Parkinson's disease

Published: October 03, 2025

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar.

In-house assays for detecting anti-SARS-CoV-2 antibodies in serum and urine: Correlation with COVID-19 severity from a cohort study in Qatar.

Journal: Journal of infection and public health

Published: December 10, 2024

Production of α-Synuclein Fibrillar-Specific scFv from Inclusion Bodies.

Production of α-Synuclein Fibrillar-Specific scFv from Inclusion Bodies.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 19, 2023

Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils.

Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils.

Journal: ACS chemical neuroscience

Published: November 09, 2022

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.

Journal: International journal of molecular sciences

Published: September 22, 2022

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 30, 2022

Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.

Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.

Journal: The FEBS journal

Published: May 11, 2021

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.

Journal: PloS one

Published: July 13, 2020

Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.

Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.

Journal: Neuroscience letters

Published: December 23, 2019

Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.

Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.

Journal: Brain pathology (Zurich, Switzerland)

Published: November 25, 2019

Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.

Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.

Journal: Scientific reports

Published: July 19, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026